Paclitaxel by 3-h Infusion and Carboplatin in Anthracycline-resistant Advanced Breast Cancer. A Phase II Study Conducted by the Hellenic Cooperative Oncology Group

By Fountzilas G.   Athanassiadis A.   Kalogera-Fountzila A.   Aravantinos G.   Bafaloukos D.   Briasoulis E.   Dombros N.   Ioannidis I.   Pavlidis N.   Kosmidis P.   Skarlos D.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1893-1895

Elsevier

Access to resources Recommend Favorite

Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer

By              

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 1985-1993

Spandidos Publications

Access to resources Recommend Favorite

Clinical Data and Pharmacokinetics of a Docetaxel-vinorelbine Combination in Anthracycline Resistant/Relapsed Metastatic Breast Cancer

By Airoldi Mario   Cattel Luigi   Pedani Fulvia   Marchionatti Sara   Tagini Valentina   Bumma Cesare   Recalenda Valeria  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 186-194

Informa Healthcare

Access to resources Recommend Favorite

Carboplatin treatment of antiestrogen-resistant breast cancer cells

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1863-1870

Spandidos Publications

Access to resources Recommend Favorite

TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer

By Villman Kenneth   Sjöström Johanna   Heikkilä Reino   Hultborn Ragnar   Malmström Per   Bengtsson Nils-Olof   Söderberg Martin   Saksela Eero   Blomqvist Carl  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 590-596

Informa Healthcare

Access to resources Recommend Favorite